World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
116
Citations
65089
World Ranking
4289
National Ranking
2345

Russell K. Portenoy publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Russell K. Portenoy sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 511 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Russell K. Portenoy D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Russell K. Portenoy sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 116 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Russell K. Portenoy is affiliated with the Albert Einstein College of Medicine in the United States. Their work is situated primarily within the field of Medicine, with a total of 89 publications. Major subfields of study include Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health, General Health Professions, Anesthesiology and Pain Medicine, and Pulmonary and Respiratory Medicine.

Research topics frequently addressed in their publications encompass:

  • Palliative Care and End-of-Life Issues
  • Cystic Fibrosis Research Advances
  • Pain Management and Opioid Use
  • Geriatric Care and Nursing Homes
  • Childhood Cancer Survivors' Quality of Life
  • Transcranial Magnetic Stimulation Studies
  • Grief, Bereavement, and Mental Health

Their recent papers demonstrate a focus on clinical oncology, palliative care, and pain management, including studies such as:

  • Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial (2023) published in Journal of Clinical Oncology
  • Family Meetings in Palliative Care: Benefits and Barriers (2022) published in Current Treatment Options in Oncology
  • Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness: A Randomized Clinical Trial (2020) published in UNC Libraries
  • Attitudes and Beliefs Toward Advance Care Planning Among Underserved Chinese-American Immigrants (2020) published in Journal of Pain and Symptom Management
  • Prescription Opioids Dispensed to Patients with Cancer with Bone Metastasis: 2011-2017 (2021) published in The Oncologist

Frequent co-authors collaborating with Portenoy include:

  • Lara Dhingra
  • Stephanie DiFiglia
  • Rachel W. Linnemann
  • Maria Berdella
  • Catherine Kier

Portenoy's work has been disseminated predominantly through journals such as the Journal of Cystic Fibrosis, Journal of Pain and Symptom Management, Journal of Palliative Medicine, Journal of Clinical Oncology, and UNC Libraries. The highest number of their publications appear in the Journal of Cystic Fibrosis.

Best Publications

  • Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

    H A Burris;M J Moore;J Andersen;M R Green

  • Pharmacologic management of neuropathic pain: evidence-based recommendations.

    Robert H. Dworkin;Alec B. O'Connor;Miroslav Backonja;John T. Farrar

  • Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain

    Roger Chou;Gilbert J. Fanciullo;Perry G. Fine;Jeremy A. Adler

  • The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress

    R.K. Portenoy;H.T. Thaler;A.B. Kornblith;J. McCarthy Lepore

  • Oxford Textbook of Palliative Medicine

    Geoffrey W. C. Hanks;Nathan I. Cherny;Nicholas A. Christakis;Marie T. Fallon

  • Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition

    Gregory A. Curt;William Breitbart;David Cella;Jerome E. Groopman

  • Management of cancer pain

    Russell K Portenoy;Pauline Lesage

  • Breakthrough pain: definition, prevalence and characteristics

    Russell K. Portenoy;Neil A. Hagen

  • Defining the clinically important difference in pain outcome measures

    John T. Farrar;Russell K. Portenoy;Jesse A. Berlin;Judith L. Kinman

  • Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases

    Russell K. Portenoy;Kathleen M. Foley

  • Breakthrough pain: characteristics and impact in patients with cancer pain

    Russell K. Portenoy;David Payne;Paul Jacobsen

  • Symptom prevalence, characteristics and distress in a cancer population

    R. K. Portenoy;H. T. Thaler;A. B. Kornblith;J. McCarthy Lepore

  • Opioids and the treatment of chronic pain: controversies, current status, and future directions.

    Andrew Rosenblum;Lisa A. Marsch;Herman Joseph;Russell K. Portenoy

  • An international survey of cancer pain characteristics and syndromes

    Augusto Caraceni;Russell K. Portenoy

  • The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions.

    Russell K. Portenoy;Kathleen M. Foley;Kathleen M. Foley;Charles E. Inturrisi

  • Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life.

    Nessa Coyle;Jean Adelhardt;Kathleen M. Foley;Russell K. Portenoy

  • A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

    M. L. Rothenberg;M. J. Moore;M. C. Cripps;J. S. Andersen

  • Opioid therapy for chronic nonmalignant pain: a review of the critical issues

    Russell K. Portenoy

  • Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial

    Joseph S. Gimbel;Patricia Richards;Russell K. Portenoy

  • The measurement of symptoms in children with cancer.

    John J. Collins;Maura E. Byrnes;Ira J. Dunkel;Jeanne Lapin

Frequent Co-Authors

Kathleen M. Foley
Kathleen M. Foley Memorial Sloan Kettering Cancer Center
Eduardo Bruera
Eduardo Bruera The University of Texas MD Anderson Cancer Center
Stein Kaasa
Stein Kaasa Oslo University Hospital
Nicholas A. Christakis
Nicholas A. Christakis Yale University
Howard T. Thaler
Howard T. Thaler Memorial Sloan Kettering Cancer Center
Richard B. Lipton
Richard B. Lipton Albert Einstein College of Medicine
John T. Farrar
John T. Farrar University of Pennsylvania
Charles S. Cleeland
Charles S. Cleeland The University of Texas MD Anderson Cancer Center
David C. Currow
David C. Currow Flinders University
William Breitbart
William Breitbart Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine in the USA offers diverse opportunities, both for clinical and non-clinical professionals. Online education is making it easier than ever to enter healthcare fields or advance your current medical career. For example, an online degree in nutrition equips students with knowledge about wellness and dietary science, supporting careers in public health, clinical settings, or private consulting.

Those interested in healthcare leadership can pursue online mha programs cahme accredited, tailored for aspiring healthcare administrators seeking flexible, high-quality education. Registered nurses looking to complete their bachelor's can benefit from rn to bsn programs, many of which offer coursework without traditional clinical requirements.

For advanced practice nurses, pursuing the fastest dnp online program can accelerate career progression into leadership, education, or specialized practice roles. Each of these pathways offers a combination of flexibility, career advancement, and the skills necessary to thrive in today’s healthcare landscape.

Best Scientists Citing Russell K. Portenoy

Trending Scientists